Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zoster vaccine for immunocompetent ... The incidence of herpes zoster was 5.4 cases vs. 11.1 cases per 1000 ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.

About SHINGRIX (Recombinant Zoster Vaccine or RZV) SHINGRIX is a non ... for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on ...

Likewise, the association with herpes zoster infection was found ... than tetanus-diphtheria-pertussis and influenza vaccines ...

The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...

In persons aged 50 years and over (i.e., 40% of the European population by 2020), HZ and its most common complication PHN cause significant morbidity and pain, reduced QoL and loss of dependency.

GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...

Findings showed a noninferior immune response for both vaccines when coadministered ... and Shingrix (zoster vaccine recombinant, adjuvanted). The open-label study included 530 adults aged 50 ...

About SHINGRIX(Recombinant Zoster Vaccine or RZV ... Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.